Triventures

Triventures is a global, early-stage venture capital firm investing in disruptive ventures with innovative breakthroughs in healthcare and beyond.

Venture Capital Active Herzliya, Israel Est. 2010
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
8
in our dataset
Rounds participated
15
Rounds led
5
Rounds' value
$192.7M
total disclosed, rounds participated
Stages
A Round, B Round, Seed, Pre-Seed

About

Founded in 2010, Triventures is a global, early-stage venture capital firm with offices in Israel and Silicon Valley. The firm invests in innovative companies that converge technology and healthcare to solve critical industry challenges. Triventures initially focused on medical devices and later expanded into digital health, fintech, cybersecurity, and e-commerce, driving innovation across various industries. They partner with exceptional entrepreneurs to build companies that can make better health possible through data-driven solutions and cross-industry convergence. The team leverages extensive experience in entrepreneurship and investment, having guided over 30 companies to successful exits.

Portfolio · 8

GI Trak (Belly)
A virtual care management platform for patients with chronic digestive issues, offering AI tools for personalized care.
Led ★ 1 round $1.3M committed Latest: 2025-12
TailorMed
TailorMed provides an end-to-end solution that removes access, affordability, and adherence barriers across the medication journey, connecting patients to resources within the nation's largest and most diverse network.
Led ★ 3 rounds $66.0M committed Latest: 2024-11
Monogoto
Monogoto is a cloud-based cellular network and software-defined connectivity platform for IoT and private networks.
2 rounds $38.0M committed Latest: 2024-10
BioProtect
Developer of biodegradable balloon implants designed to protect healthy tissue during radiation therapy for prostate cancer.
1 round $28.0M committed Latest: 2023-09
FeelBetter
FeelBetter is an AI-powered platform that optimizes medication management for patients, particularly those with complex regimens and multiple chronic conditions.
Led ★ 3 rounds $8.0M committed Latest: 2023-07
Flow
Provider of AI-enabled smart cart solution for offline retailers.
2 rounds $20.6M committed Latest: 2023-04
CathWorks
Developer of angiogram-based physiology measurement solution for coronary artery disease.
Led ★ 1 round $15.8M committed Latest: 2017-10
OrthoSpace
Developer of biodegradable balloon systems for rotator cuff syndrome.
Led ★ 2 rounds $15.0M committed Latest: 2016-12

Investment activity

7 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences20
Cyber Security1
Business Software1
Fintech & Insurtech1

Funds · 4

  • Triventures ARC — $40M Sep 2019
  • 4 — $40M Jun 2019
  • 2 — $30M May 2015
  • 3 — $75M May 2015

Q&A

What is Triventures' primary investment focus?
Triventures is a global, early-stage fund that invests in disruptive ventures with innovative breakthroughs in healthcare and beyond.
Which sectors does Triventures primarily invest in?
Triventures primarily invests in Health Tech & Life Sciences, accounting for 20 of its portfolio companies. They also have investments in Cyber Security, Business Software, and Fintech & Insurtech.
Can you name some of Triventures' recent notable exits?
Triventures has had several notable exits, including CathWorks, which was acquired by Medtronic for $585M in February 2026, and BioProtect, acquired by Almeda Ventures for $200M in January 2026.
What are some of the investment stages Triventures participates in?
Triventures invests across various stages, including Pre-Seed, Seed, A Round, and B Round.
When was Triventures founded and where is it headquartered?
Triventures was founded in 2009 and is headquartered in Herzliya, Israel.
Who are the co-founders of Triventures?
The co-founders of Triventures are Martin Leon, Peter Fitzgerald, and Michal Geva.
What is the most recent fund raised by Triventures?
Triventures raised its Triventures ARC fund in September 2019, with an amount of $40M.
What was the acquisition value for Genoox, a Triventures portfolio company?
Genoox was acquired by Qiagen for $80M in May 2025.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)